News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

To Fend Off Pfizer Inc. (PFE), AstraZeneca PLC (AZN) Contemplating Sale Of Some Future Revenue From Existing Drugs



6/23/2014 6:21:41 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

According to a Financial Times report Friday citing people familiar with the matter, AstraZeneca is working with bankers on the potential sale of rights to future revenue streams from certain existing drugs. The report suggested the move could make AstraZeneca less appealing to recent suitor Pfizer by eliminating access to some future income in the event of a takeover, while also generating billions in revenue that could be returned to shareholders or used to fund R&D.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES